ANTHRACYCLINE ANTIBIOTIC/TOPOISOMERASE INHIBITOR
Adriamycin, also known by its drug name, Doxorubicin, is a prescription medication approved by the Food and Drug Administration (FDA) for treating Hodgkin lymphoma, non-Hodgkin lymphoma (NHL), and multiple myeloma. Adriamycin is often combined with other drugs in specific chemotherapy regimens.
Adriamycin is an anticancer drug used in chemotherapy. Adriamycin is a member of a drug class called anthracycline antibiotics. Adriamycin is also a topoisomerase inhibitor. Adriamycin is believed to work by damaging DNA and blocking cell division in several different ways.
How do I take it?
Adriamycin is usually administered as an intravenous infusion during chemotherapy treatment.read more
The FDA-approved label for Adriamycin lists common side effects including fever, chills, nausea, vomiting, abdominal pain, diarrhea, hair loss, rash, itching, darkening of the skin, nails, and inside of the mouth, loss of appetite, fatigue, and increased risk for infection.
Rare but serious side effects listed for Adriamycin include heart damage or inflammation, severe damage to skin at injection sites, fetal harm in pregnant women, premature menopause in women, infertility in men, and increased risk for some types of cancer, even years after treatment has stopped.
For more details about this treatment, visit:
Adriamycin PFS – RxList
Chemotherapy for Hodgkin Lymphoma – American Cancer Society
Chemotherapy for Non-Hodgkin Lymphoma – American Cancer Society
Drug Therapy for Multiple Myeloma – American Cancer Society